Authors
Latest:
AI/ML Approaches to Assisted Medical Writing—Part 2Following a discussion around summarization in Part 1, Part 2 discusses the method of pure abstraction in light of recent advances in deep learning and AI.
Latest:
Enhancing Enrollment in Biomarker-Driven Oncology and Rare Disease TrialsIntegrated approaches can help enhance recruitment plans.
Latest:
eSource Interoperability Between EHR and EDCEvidence from a Phase III cancer trial points to notable advances in data-transfer tech.
Latest:
Ten Considerations for Sensor Selection in Clinical TrialsThe careful selection of sensor technology prioritized in clinical trials, considering regulatory compliance, data security, device characteristics, and the specific needs of the trials for successful and confident implementation.
Latest:
From Physician to Pharma: Gynecologic Oncologist Enters Clinical Trials SpaceIn an interview with Applied Clinical Trials' sister publication, Pharmaceutical Executive, Elizabeth (Beth) Garner, chief scientific officer for Ferring Pharmaceuticals, discusses what it was like transitioning from working as a gynecologic oncologist and seeing patients to working in pharma, specifically clinical trials.
Latest:
Establishing a Basis for Secondary Use Standards for Clinical TrialsStudy seeks to understand how different forms of data meet the needs of researchers.
Latest:
Collaborative Strategies for Technology Integration in Clinical StudiesAddressing data integrity and compliance concerns.
Latest:
Clinical Trial Disclosure and Data Transparency: Obligation or Opportunity?Implementing disclosure and data transparency policies and procedures represents an opportunity for sponsors, rather than an obligation.
Latest:
Focus on Fundamentals for Better Collaboration Across Research Sites and SponsorsImproving the site-sponsor relationship can get trials off on the right foot and on a path for success.
Latest:
Can Clinical Trials Overcome Their Staffing Problem?The current lack of clinical trial professionals is a serious concern that's compromising the ability to conduct high-quality clinical trials, but it's not irreversible.
Latest:
The Two Guiding Principles of Optimal Trial DeliveryTrust-based relationships form the foundation for successful trial management.
Latest:
Innovations in Data Capture Transforming Trial DeliveryAdvances in technology open door for improved EHR to EDC transfer process.
Latest:
Awareness of Clinical Research Increases Among Underrepresented GroupsLatest CISCRP study provides insight on proactive outreach.
Latest:
Rebadging Gains Momentum Amidst COVIDCapacity management and stability offer value for clients, their employees and FSP vendors.
Latest:
The Future of Clinical Trials: Turning Data Chaos into Trial IntelligencePoll taken by leading biotech executives in clinical development addresses state of data quality and management.
Latest:
Introducing PALADINFirst-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
Latest:
Opportunities for Improving Clinical Decisions with Patient Centric Remote Blood Sampling ApproachesThis article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.
Latest:
Revolutionizing Clinical Data Management: The Leap from Deterministic to AI-Powered Stochastic MethodsLeveraging artificial intelligence-powered stochastic methods for clinical data review represents a significant leap beyond traditional approaches.
Latest:
Empowered Trial Selection with Weighting and Prioritization ToolsThursday, September 30, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Give yourself a competitive edge by learning how the world’s leading designer of innovative clinical trials can help you integrate elements of economic theory to your clinical trial design. Optimize sample size, speed, and power by exploring a broader array of designs and quickly identifying those that meet your objectives.
Latest:
The CRA of the Future: From ‘Road Warrior’ to Site ‘Owner’Adjusting to the changing dynamics of the clinical research associate role.
Latest:
The Rise of Gene Therapy: Advanced Regulatory, Site, and Enrollment ConsiderationsDeveloping new pathways to overcome study-related challenges is key to realizing the promise of the latest gene therapies.
Latest:
Diversity in Clinical Trials: Strategies and ChallengesWhy weighing all of the ‘DE&I’ components is critical at site and sponsor levels.
Latest:
Thoughtful Design in eCOA Development: Part 2To derive the greatest benefits from eCOA technology, several elements must work together to create a strong foundation for sponsor success.
Latest:
Managing Biospecimens in Cell and Gene Therapy TrialsPursuing new tools and capabilities in sample logistics, storage, and data analysis.
Latest:
Benchmarking the Investigative Site Qualification ProcessInsights identify opportunities to optimize sponsor, CRO, and site collaborations.
Latest:
Unleashing Their Potential: The Evolving Landscape of DHTsKey considerations in deploying fit-for-purpose digital health technologies in drug development.
Latest:
Harnessing Patient-Centered Science to Improve Health Outcomes and Commercial Pharma SuccessGood scientific principles and practices are essential for maintaining quality data that patients can benefit from.
Latest:
Scaling eSource-Enabled Clinical Trials: Hospital PerspectivesThe challenges, opportunities, and strategic outlook for oncology research centers.
Latest:
Build Relationships with HCPs to Reach Potential Clinical Trial PatientsIncreased outreach is necessary to combat poor recruitment and large focus on patients near study centers.
